Dissecting fake news and violations of scientific ethics in scientific publications: analysis of the article “Hyperglycosylation is a metabolic driver of Alzheimer's disease”

Glucosamine in the form of glucosamine sulfate is used in the treatment of osteoarthritis, including in patients with concomitant diabetes, obesity, chronic ischemia, and neurodegenerative diseases (such as Alzheimer's disease). In addition to its chondroprotective effects, glucosamine sulfate is well known to exert hepatoprotective and neuroprotective effects. Despite the considerable body of basic and clinical research on this subject, “unexpected” articles occasionally appear in scientific journals published by reputable publishers that contradict not only the existing body of evidence but also common sense. Such publications often generate undesirable media attention, which may ultimately have a profoundly negative impact on patient care. This article presents the results of a detailed analysis of one such article, published in “Nature Metabolism” in 2026. Expert analysis identified the following: (1) the absence of verifiable data indicating that the reported experiments were actually performed; (2) apparent ethical violations in the reported medical procedures, including claims that frontal cortex samples were collected from patients with Alzheimer's disease; (3) numerous logical and quantitative inconsistencies in the reported results of biochemical and experimental studies; (4) major errors in the clinical characterization and analysis of the reported patient cohorts (e.g., 10-year dynamics over 5 years of observation); (5) formulaic use of vague or overly general terms throughout the article, including in the Results (“hyperglycosylation”, “glycosylation phenotype”, etc.); (6) apparent statistical artifacts (e.g., increases of exactly 25% in a wide variety of outcomes, including mortality from Alzheimer's disease due to glucosamine use); and (7) insufficient knowledge of the biochemistry of protein glycosylation on the part of the authors. It should be emphasized that entire sections of the article under review contain numerous logical errors and internally contradictory statements that can be summarized as “the toxic effect of a nontoxic substance” or “the detoxifying effect of a highly toxic effect”. It is hypothesized, based in part on the text of the publication itself, that the article published in “Nature Metabolism” was prepared using information technologies such as ChatGPT.

Authors

Institutions

Publication Details

Journal
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology
Published
2026-10-29
DOI
https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.406
Primary Topic
Academic integrity and plagiarism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dissecting fake news and violations of scientific ethics in scientific publications: analysis of the article “Hyperglycosylation is a metabolic driver of Alzheimer's disease”

Ольга Алексеевна Громова, А. Г. Чучалин, Ivan Yu. Torshin
1 links
FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology
Academic integrity and plagiarism
article

Dissecting fake news and violations of scientific ethics in scientific publications: analysis of the article “Hyperglycosylation is a metabolic driver of Alzheimer's disease”

Ольга Алексеевна Громова, А. Г. Чучалин, Ivan Yu. Torshin
article en

Abstract

Glucosamine in the form of glucosamine sulfate is used in the treatment of osteoarthritis, including in patients with concomitant diabetes, obesity, chronic ischemia, and neurodegenerative diseases (such as Alzheimer's disease). In addition to its chondroprotective effects, glucosamine sulfate is well known to exert hepatoprotective and neuroprotective effects. Despite the considerable body of basic and clinical research on this subject, “unexpected” articles occasionally appear in scientific journals published by reputable publishers that contradict not only the existing body of evidence but also common sense. Such publications often generate undesirable media attention, which may ultimately have a profoundly negative impact on patient care. This article presents the results of a detailed analysis of one such article, published in “Nature Metabolism” in 2026. Expert analysis identified the following: (1) the absence of verifiable data indicating that the reported experiments were actually performed; (2) apparent ethical violations in the reported medical procedures, including claims that frontal cortex samples were collected from patients with Alzheimer's disease; (3) numerous logical and quantitative inconsistencies in the reported results of biochemical and experimental studies; (4) major errors in the clinical characterization and analysis of the reported patient cohorts (e.g., 10-year dynamics over 5 years of observation); (5) formulaic use of vague or overly general terms throughout the article, including in the Results (“hyperglycosylation”, “glycosylation phenotype”, etc.); (6) apparent statistical artifacts (e.g., increases of exactly 25% in a wide variety of outcomes, including mortality from Alzheimer's disease due to glucosamine use); and (7) insufficient knowledge of the biochemistry of protein glycosylation on the part of the authors. It should be emphasized that entire sections of the article under review contain numerous logical errors and internally contradictory statements that can be summarized as “the toxic effect of a nontoxic substance” or “the detoxifying effect of a highly toxic effect”. It is hypothesized, based in part on the text of the publication itself, that the article published in “Nature Metabolism” was prepared using information technologies such as ChatGPT.

FARMAKOEKONOMIKA Modern Pharmacoeconomics and PharmacoepidemiologyVol. 19(3)
Russian Academy of Sciences (RU), Pirogov Russian National Research Medical University (RU), Federal Research Center “Computer Science and Control” of the Russian Academy of Sciences (RU)
Good health and well-being
Openalex Percentile: Top 8%
Academic integrity and plagiarism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon